Takeda taps Lilly exec to run U.S. unit, adding a woman to its all-male exec team

Takeda has chosen a woman to run its U.S. pharma business, just weeks after new CEO Christophe Weber said he was unhappy with the gender balance in the Japanese drugmaker's management ranks. Weber recruited Eli Lilly ($LLY) USA exec Ramona Sequeira to replace Doug Cole, who announced his departure last November. More from FiercePharmaAsia | Release